Daniel Joseph Apel
CIK: 0002081169
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARROWHEAD PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 22, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct3.2K shares at avg. $70.11$225K - Apr 22, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $70.45$82K - Apr 22, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Sale(S)Direct8.7K shares at avg. $71.92$628K - Jan 6, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 22, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 3,208 | $70.11 | $224,913 | Direct |
| Apr 22, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 1,157 | $70.45 | $81,511 | Direct |
| Apr 22, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale(S) | 8,730 | $71.92 | $627,862 | Direct |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 75,000 | - | $0 | Direct |
1-4 of 4 transactions
About Apel Daniel Joseph
Apel Daniel Joseph (SEC CIK 0002081169) files insider reports with the SEC as Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
Signal8 holds 3 ownership filings by Apel Daniel Joseph (1 Form 3, 2 Form 4), filed between Aug 12, 2025 and Apr 24, 2026. Those filings report 4 transactions, from Jan 6, 2026 to Apr 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Apel Daniel Joseph's filings is in PASADENA, CA.
Recent filings by Apel Daniel Joseph
Other insiders filing for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
- OLUKOTUN ADEOYE Y, Director
- PERRY MICHAEL S, Director
- Cohen Matthew Gregory, Director
- Lu Hongbo, Director
- Hamilton James C, Chief Medical Officer
- O'Brien Patrick, COO